Search

everythinglearnresearchcommunity

for

Search:↓

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Radiation cystitis patients need better monitoring and early treatment due to higher readmission rates.

High TSPEAR levels in colorectal cancer predict worse outcomes.

Adding stromal vascular fraction to platelet-rich plasma injections did not significantly improve hair growth in androgenetic alopecia treatment.

Platelet-rich plasma injections made hair thicker for both men and women, with a greater effect in women.

The health of the sentinel lymph node is the best indicator of survival for patients with thick skin cancer.

Most people in Alahsa, Saudi Arabia, have low awareness of thyroid disease symptoms and risk factors.

Forehead modification greatly increases the perception of femininity and is a safe procedure.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

Post-finasteride syndrome's existence is uncertain; more research needed.

People with androgenetic alopecia are more likely to have metabolic syndrome.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

The document concludes that careful planning and execution of facial gender affirmation surgery after at least 12 months of hormonal therapy can improve the quality of life for transgender individuals.

Synthetic cannabinoid addiction can cause skin problems like acne and hair loss.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

The treatment helped a transgender woman stop drinking, improved her mental health, and reduced her gender dysphoria.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

BMI is not a significant predictor of complications after gender-affirming penile inversion vaginoplasty.

Children and adults with Cushing's disease show different symptoms and males have more severe cases; surgery outcomes can be predicted by certain factors.

No clear link between hair loss and metabolic syndrome, but some differences in blood pressure and glucose levels.

The document concludes that facial feminization surgery improves psychological well-being and social acceptance for transgender individuals.

Lupus panniculitis of the scalp causes linear hair loss and needs ongoing treatment to prevent recurrence and lupus.

Acne was the most common skin problem in kids, with other conditions like warts and eczema also frequent, varying by age and gender.

New niosomal formulation effectively delivers aminexil through rat skin.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

Early-onset hair loss in young males is linked to a higher risk of metabolic syndrome.